4.6 Article

Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: A matched retrospective cohort study

Journal

BRAIN STIMULATION
Volume 11, Issue 1, Pages 204-212

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.brs.2017.10.009

Keywords

Electroconvulsive therapy; Depression; Borderline personality disorder; Posttraumatic stress disorder; Clinical research

Funding

  1. Ontario Ministry of Health and Long Term Care - AFP Innovation Fund

Ask authors/readers for more resources

Background: The impact of comorbid borderline personality disorder (BPD) or post-traumatic stress disorder (PTSD) on clinical and cognitive outcomes of electroconvulsive therapy (ECT) in patients with major depressive episodes (MDE) is unknown. Objective: Compare clinical response and adverse cognitive effects for MDE patients with comorbid BPD or PTSD to MDE only. Methods: In a matched retrospective cohort study of 75 patients treated with ECT at an academic psychiatric hospital with DSM-IV MDE and either comorbid BPD, PTSD or both (MDE thorn BPD/PTSD), 75 MDE patients without BPD or PTSD (MDE-only) were matched. We reviewed clinical records to determine treatment response by estimating clinical global impression of improvement (c-CGI) and presence of adverse cognitive effects based on subjective distress or objective impairment. We explored factors associated with response and cognitive effects in the MDE thorn BPD/PTSD group. Results: There was no difference in c-CGI response rates between groups (p > 0.017). Secondary analysis of inpatients found lower response rates for MDE thorn BPD (55.4%) and MDE thorn BPD thorn PTSD (55.8%) than MDE-only (82.5%), but not MDE thorn PTSD (65.0%). There was no difference in adverse cognitive effects in the MDE thorn BPD/PTSD (23.3%-26.8%) group compared to MDE-only (25.0%). In the MDE thorn BPD/PTSD group, factors associated with higher response rate were: referral indications other than failed pharmacotherapy, greater number of ECT treatments, presence of adverse cognitive effects, and seizure duration > 30 s. Conclusions: Despite a lower c-CGI response for inpatients with MDE thorn BPD, ECT is a viable treatment option for patients in the MDE thorn BPD/PTSD group with similar adverse cognitive effect profiles to MDE-only. (c) 2017 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairment

Neda Rashidi-Ranjbar, Tarek K. Rajji, Colin Hawco, Sanjeev Kumar, Nathan Herrmann, Linda Mah, Alastair J. Flint, Corinne E. Fischer, Meryl A. Butters, Bruce G. Pollock, Erin W. Dickie, Christopher R. Bowie, Matan Soffer, Benoit H. Mulsant, Aristotle N. Voineskos

Summary: This study compared resting state functional connectivity in older adults with major depressive disorder (MDD) or mild cognitive impairment (MCI), and found that the alterations in functional connectivity in certain brain networks were associated with an increased risk of cognitive impairment.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Endocrinology & Metabolism

Factors Associated With Initiation of Antidepressant Medication in Adults With Type 1 and Type 2 Diabetes: A Primary Care Retrospective Cohort Study in Ontario, Canada

Osnat C. Melamed, Sumeet Kalia, Rahim Moineddin, Michelle Greiver, Stefan Kloiber, Benoit H. Mulsant, Peter Selby, Braden G. O'Neill

Summary: This study aims to identify demographic, socioeconomic and medical factors associated with the initiation of antidepressant medication in adult patients with diabetes. The study found that younger age, female gender, insulin treatment, and polypharmacy were associated with higher odds of antidepressant initiation. Patients also had increased visits to primary care after antidepressant initiation.

CANADIAN JOURNAL OF DIABETES (2023)

Article Psychology, Clinical

Self- Versus Informant-Report of Cognitive Decline in Mild Cognitive Impairment: Concordance With Cognitive and Functional Performance

Melissa Milanovic, Chelsea Wood-Ross, Meryl A. Butters, Corinne E. Fischer, Alastair J. Flint, Philip Gerretsen, Nathan Herrmann, Krista L. Lanctot, Linda Mah, Benoit H. Mulsant, Bruce G. Pollock, Tarek K. Rajji, Christopher R. Bowie

Summary: This study assessed the concordance between self-report and informant-report of cognitive decline, and compared them with objective cognitive and functional performance. The results showed a poor concordance between self-report and informant-report of cognitive decline in patients with mild cognitive impairment. Underestimators of cognitive decline had lower objective cognitive and functional performance. Cognitive performance significantly predicted functional performance in all groups, and this relationship was influenced by the discrepancy between self-report and informant-report.

NEUROPSYCHOLOGY (2023)

Correction Psychiatry

Cognitive-behavioral social skills training for patients with late-life schizophrenia and the moderating effect of executive dysfunction (vol 239, pg 160, 2022)

Tarek K. Rajji, David C. Mamo, Jason Holden, Eric Granholm, Benoit H. Mulsant

SCHIZOPHRENIA RESEARCH (2023)

Article Geriatrics & Gerontology

Late-Life Depression is Associated With Increased Levels of GDF-15, a Pro-Aging Mitokine

Emma Mastrobattista, Eric J. Lenze, Charles F. Reynolds, Benoit H. Mulsant, Julie Wetherell, Gregory F. Wu, Daniel M. Blumberger, Jordan F. Karp, Meryl A. Butters, Ana Paula Mendes-Silva, Erica L. Vieira, George Tseng, Breno S. Diniz

Summary: This study assessed the levels of GDF-15 in 393 older adults, including 308 with major depressive disorder (MDD) and 85 non-depressed individuals. The results showed that older adults with MDD had significantly higher levels of GDF-15, which were associated with physical comorbidity burden, cognitive decline, and late-onset depression.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Article Geriatrics & Gerontology

Recruiting for a Randomized Clinical Trial for Late-Life Depression During COVID-19: Outcomes of Provider Referrals Versus Facebook Self-Referrals

Nicholas J. Ainsworth, Hailey Wright, Ksenya Tereshchenko, Daniel M. Blumberger, Alastair J. Flint, Eric J. Lenze, Athina Perivolaris, Benoit H. Mulsant

Summary: This study evaluated the effectiveness of online recruitment for a clinical trial of pharmacotherapy for late-life depression during COVID-19. The study found that provider referrals had a higher yield compared to Facebook self-referrals. Participants who self-referred from Facebook had higher education levels. Future research should assess the cost-effectiveness and potential barriers of online recruitment.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Article Geriatrics & Gerontology

Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition

Hanadi Ajam Oughli, Marie Anne Gebara, Adam Ciarleglio, Helen Lavretsky, Patrick J. Brown, Alastair J. Flint, Nuri B. Farber, Jordan F. Karp, Benoit H. Mulsant, Charles F. Reynolds, Steven P. Roose, Lei Yang, Meryl A. Butters, Eric J. Lenze

Summary: This pilot study suggests that repeated IV ketamine infusions are well-tolerated and associated with improvement in depression and executive function in older adults with TRD. These promising findings need to be confirmed and extended in a larger randomized controlled trial.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Article Clinical Neurology

Bipolar I and bipolar II subtypes in older age: Results from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) project

Alexandra J. M. Beunders, Federica Klaus, Almar A. L. Kok, Sigfried N. T. M. Schouws, Ralph W. Kupka, Hilary P. Blumberg, Farren Briggs, Lisa T. Eyler, Brent P. Forester, Orestes Forlenza, Ariel Gildengers, Esther Jimenez, Benoit H. Mulsant, Regan E. Patrick, Soham Rej, Martha Sajatovic, Kaylee Sarna, Ashley Sutherland, Joy Yala, Eduard Vieta, Luca M. Villa, Nicole C. M. Korten, Annemieke Dols

Summary: This study compared bipolar I disorder (BD-I) and bipolar II disorder (BD-II) in a large, global sample and found no significant differences between the two in terms of general functioning, cognition, and somatic burden. These findings suggest that the distinction between BD-I and BD-II may not be applicable to geriatric bipolar disorder patients.

BIPOLAR DISORDERS (2023)

Article Psychiatry

Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial

Alastair J. Flint, Kathleen S. Bingham, George S. Alexopoulos, Patricia Marino, Benoit H. Mulsant, Nicholas H. Neufeld, Anthony J. Rothschild, Aristotle N. Voineskos, Ellen M. Whyte, Barnett S. Meyers

Summary: This study aimed to identify a prediction model for the risk of relapse in psychotic depression and examine if predictors moderated the effect of treatment on relapse. The number of depressive episodes, severity of residual depressive symptoms, and psychomotor disturbance predicted the risk of relapse. Multivariable models had an accuracy of 69-70% in predicting relapse. Future research is needed to determine if a combination of clinical and biological variables can improve the accuracy of predicting relapse in psychotic depression.

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

Review Psychiatry

A systematic review on the effectiveness of dialectical behavior therapy for improving mood symptoms in bipolar disorders

Brett D. M. Jones, Madeha Umer, Mary E. Kittur, Ofer Finkelstein, Siqi Xue, Mikaela K. Dimick, Abigail Ortiz, Benjamin I. Goldstein, Benoit H. Mulsant, Muhammad I. Husain

Summary: This systematic review examined the efficacy of dialectical behavior therapy (DBT) for mood symptoms in patients with bipolar disorder (BD), finding that DBT may be effective in improving core symptoms of BD. However, limited sample sizes, heterogeneity, and high risk of bias in the included trials limit the confidence in this conclusion. Larger, well-designed randomized controlled trials are needed to establish the effectiveness of DBT in BD.

INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2023)

Article Health Care Sciences & Services

Technology-Enabled Collaborative Care for Concurrent Diabetes and Distress Management During the COVID-19 Pandemic: Protocol for a Mixed Methods Feasibility Study

Lenka Vojtila, Diana Sherifali, Rosa Dragonetti, Iqra Ashfaq, Scott Veldhuizen, Farooq Naeem, Sri Mahavir Agarwal, Osnat C. Melamed, Allison Crawford, Philip Gerretsen, Margaret Hahn, Sean Hill, Sean Kidd, Benoit Mulsant, Eva Serhal, Leah Tackaberry-Giddens, Carly Whitmore, Jennifer Marttila, Frank Tang, Seeta Ramdass, Gloria Lourido, Sanjeev Sockalingam, Peter Selby

Summary: This study aims to test the feasibility of a technology-enabled collaborative care (TECC) model for diabetes management and mental health support among adults with T2D. Thirty adults with T2D in Ontario, Canada will participate in an 8-week web-based health coaching program supported by a digital care team. The study results, expected to be available by the end of 2023, will provide valuable insights for supporting individuals with T2D and mental health challenges.

JMIR RESEARCH PROTOCOLS (2023)

Article Clinical Neurology

Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression-The STOP-PD II Study

Jianmeng Song, Benoit H. Mulsant, Marcos Sanches, George S. Alexopoulos, Patricia Marino, Barnett S. Meyers, Anthony J. Rothschild, Aristotle N. Voineskos, Ellen M. Whyte, Alastair J. Flint, Philip Gerretsen, STOP-PD I. I. Study Group Behalf STOP PD II Study Grp

Summary: This study examined the relationship between participant characteristics and impaired insight into delusions in remitted psychotic depression, as well as whether impaired insight is associated with risk of relapse during continuation pharmacotherapy. The results showed that the severity of psychosis before treatment initiation was the only participant characteristic associated with the change in insight. Neither change in insight nor insight at the end of stabilization treatment predicted risk of relapse.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Review Psychiatry

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

Muhammad Ishrat Husain, Nicole Ledwos, Elise Fellows, Jenna Baer, Joshua D. Rosenblat, Daniel M. Blumberger, Benoit H. Mulsant, David J. Castle

Summary: This article reviews the mechanisms underlying the antidepressant effect of serotonergic psychedelics, including their serotonin 2A agonist effects, impact on brain derived neurotrophic factor and immunomodulatory responses, and disruption of the default mode network. However, further research is needed to validate these mechanisms and determine which theories are supported by robust evidence.

FRONTIERS IN PSYCHIATRY (2023)

Article Medicine, General & Internal

Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression A Randomized Clinical Trial

M. Ishrat Husain, Imran B. Chaudhry, Ameer B. Khoso, Tayyeba Kiran, Nawaz Khan, Farooq Ahmad, John Hodsoll, M. Omair Husain, Haider A. Naqvi, Asad T. Nizami, Nasim Chaudhry, Hazrat A. Khan, Fareed Minhas, Jeffrey H. Meyer, Moin A. Ansari, Benoit H. Mulsant, Nusrat Husain, Allan H. Young

Summary: This study aimed to assess the efficacy and tolerability of adjunctive simvastatin in reducing depressive symptoms in treatment-resistant depression (TRD). The results showed no significant differences between the simvastatin group and the placebo group in primary and secondary outcomes, and there were also no significant differences in adverse effects between the two groups. Therefore, simvastatin did not provide additional therapeutic benefit for depressive symptoms in TRD.

JAMA NETWORK OPEN (2023)

Correction Psychiatry

Culturally adapted psychoeducation for bipolar disorder in a low-resource setting: protocol for a multicentre randomised controlled trial (vol 8, E206, 2022)

M. Ishrat Husain, Madeha Umer, Muqaddas Asif, Ameer B. Khoso, Tayyeba Kiran, Moin Ansari, Huma Aslam, Moti Ram Bhatia, Farasat A. Dogar, M. Omair Husain, Hazrat A. Khan, Ali A. Mufti, Benoit H. Mulsant, Farooq Naeem, Haider A. Naqvi, Claire de Oliveira, M. Sajjad Siddiqui, Asad Tamizuddin, Wei Wang, Juveria Zaheer, Nusrat Husain, Nasim Chaudhry, Imran B. Chaudhry

BJPSYCH OPEN (2023)

No Data Available